BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/31/2024 7:03:00 AM | Browse: 447 | Download: 1229
 |
Received |
|
2023-11-21 08:24 |
|
Peer-Review Started |
|
2023-11-21 08:24 |
|
First Decision by Editorial Office Director |
|
2023-12-08 05:49 |
|
Return for Revision |
|
2023-12-08 05:49 |
|
Revised |
|
2023-12-12 12:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-01-11 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-01-11 04:42 |
|
Articles in Press |
|
2024-01-11 04:42 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-25 06:20 |
|
Publish the Manuscript Online |
|
2024-01-31 07:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chu-Xuan Liu, Ying Gao, Xiu-Fang Xu, Xin Jin, Yun Zhang, Qian Xu, Huan-Xin Ding, Bing-Jun Li, Fang-Ke Du, Lin-Chuan Li, Ming-Wei Zhong, Jian-Kang Zhu and Guang-Yong Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Major Basic Research Project of Natural Science Foundation of Shandong Province |
ZR2020ZD15 |
|
| Corresponding Author |
Guang-Yong Zhang, MD, Chief Doctor, Professor, Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, No. 16766 Jingshi Road, Jinan 250014, Shandong Province, China. guangyongzhang@hotmail.com |
| Key Words |
Gastric cancer; Ferroptosis; Bile acids; Chenodeoxycholic acid; Farnesoid X receptor; Glutathione |
| Core Tip |
Gastric cancer (GC) is the fifth most common cancer worldwide and the third leading cause of cancer-related deaths. Bile acids (BAs) reflux is an essential carcinogenic factor in GC, but its role has not been absolutely elaborated. BAs could serve as signaling molecules to regulate the metabolic state in cells, which is closely related to ferroptosis. In the present experiment, we explored the role of BAs in the regulation of ferroptosis in GC cells. Our data suggested that BAs could significantly inhibit the ferroptosis sensitivity of GC cells and that this effect was exerted through the activation of the farnesoid X receptor-BTB and CNC homology 1-glutathione (GSH)-GSH peroxidase 4 axis. |
| Publish Date |
2024-01-31 07:03 |
| Citation |
Liu CX, Gao Y, Xu XF, Jin X, Zhang Y, Xu Q, Ding HX, Li BJ, Du FK, Li LC, Zhong MW, Zhu JK, Zhang GY. Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells. World J Gastroenterol 2024; 30(5): 485-498
|
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i5/485.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i5.485 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
